StockData
MediciNova Inc logo

MediciNova Inc (MNOV) stock

MNOVNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$1.34+0.00 (0.00%)

Close on Nov 17, 2026Market cap $65.96MP/E –Yield –

MediciNova r&d expenses

Research and development expenses are spending on new products and technology.

MediciNova's R&D Expenses for the twelve months ending Jun 30, 2026 was $5.00M, down 31.5% year over year. For fiscal 2025 it was $6.70M, down 1.5% from the year before. Over ten years it grew 9.5% a year on average. The highest annual figure on record is $10.87M in fiscal 2009.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$6.70M-1.5%
FY2024Dec 31, 2024$6.80M+28.3%
FY2023Dec 31, 2023$5.30M-39.1%
FY2022Dec 31, 2022$8.70M+7.4%
FY2021Dec 31, 2021$8.10M+14.1%
FY2020Dec 31, 2020$7.10M+24.6%
FY2019Dec 31, 2019$5.70M+7.5%
FY2018Dec 31, 2018$5.30M+35.9%
FY2017Dec 31, 2017$3.90M+25.8%
FY2016Dec 31, 2016$3.10M+14.8%
FY2015Dec 31, 2015$2.70M-6.9%
FY2014Dec 31, 2014$2.90M+7.4%
FY2013Dec 31, 2013$2.70M-40.0%
FY2012Dec 31, 2012$4.50M-42.2%
FY2011Dec 31, 2011$7.78M-19.8%
FY2010Dec 31, 2010$9.71M-10.7%
FY2009Dec 31, 2009$10.87M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$900.00K-55.0%
Q1 FY2026Mar 31, 2026$1.20M-29.4%
Q4 FY2025Dec 31, 2025$1.40M-22.2%
Q3 FY2025Sep 30, 2025$1.50M-16.7%
Q2 FY2025Jun 30, 2025$2.00M+33.3%
Q1 FY2025Mar 31, 2025$1.70M0.0%
Q4 FY2024Dec 31, 2024$1.80M+12.5%
Q3 FY2024Sep 30, 2024$1.80M+157.1%
Q2 FY2024Jun 30, 2024$1.50M-6.3%
Q1 FY2024Mar 31, 2024$1.70M+21.4%
Q4 FY2023Dec 31, 2023$1.60M-15.8%
Q3 FY2023Sep 30, 2023$700.00K-70.8%
Q2 FY2023Jun 30, 2023$1.60M-36.0%
Q1 FY2023Mar 31, 2023$1.40M-30.0%
Q4 FY2022Dec 31, 2022$1.90M+11.8%
Q3 FY2022Sep 30, 2022$2.40M+20.0%
Q2 FY2022Jun 30, 2022$2.50M+8.7%
Q1 FY2022Mar 31, 2022$2.00M0.0%
Q4 FY2021Dec 31, 2021$1.70M0.0%
Q3 FY2021Sep 30, 2021$2.00M-4.8%
Q2 FY2021Jun 30, 2021$2.30M+9.5%
Q1 FY2021Mar 31, 2021$2.00M+66.7%
Q4 FY2020Dec 31, 2020$1.70M0.0%
Q3 FY2020Sep 30, 2020$2.10M+90.9%
Q2 FY2020Jun 30, 2020$2.10M+50.0%
Q1 FY2020Mar 31, 2020$1.20M-20.0%
Q4 FY2019Dec 31, 2019$1.70M+1600.0%
Q3 FY2019Sep 30, 2019$1.10M-52.2%
Q2 FY2019Jun 30, 2019$1.40M+7.7%
Q1 FY2019Mar 31, 2019$1.50M-6.3%
Q4 FY2018Dec 31, 2018$100.00K-90.0%
Q3 FY2018Sep 30, 2018$2.30M+91.7%
Q2 FY2018Jun 30, 2018$1.30M+62.5%
Q1 FY2018Mar 31, 2018$1.60M+100.0%
Q4 FY2017Dec 31, 2017$1.00M+150.0%
Q3 FY2017Sep 30, 2017$1.20M+50.0%
Q2 FY2017Jun 30, 2017$800.00K–
Q1 FY2017Mar 31, 2017$800.00K–
Q4 FY2016Dec 31, 2016$400.00K–
Q3 FY2016Sep 30, 2016$800.00K–

More MediciNova figures

See a number that looks wrong?